Landscapes / Companies

Tanabe Pharma Corporation not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
2 in Phase 3
Next date
Elismetrep, Phase 3 trial completes
Drugs
4
in active trials · 39 in all
Trials
3 active
93 since 2021

Drugs4

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
ADC Therapeutics S.A.
Approved Aug 2028Phase 1/2 trial completes
—
Approved in Japan —
—
TriGemX Bio
Phase 3 Feb 2027Phase 3 trial completes
—
Phase 3 Apr 2029Phase 3 trial completes

About

No active trial
35 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021

Follow Tanabe Pharma Corporation

Following is part of Solo: you see every change to Tanabe Pharma Corporation the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in